Skip to Content
  • Niemann-Pick Type C
    • Research
    • General Grant Guidelines
    • Resources
    • Links
  • Get Involved
  • About DART
    • Our Leadership
    • A Tribute to Dana
    • DART Documents
    • Contact DART
  • Past Events
  • News Blog
  • Upcoming Events
  • Press Info
  • Donate Now
Dana's Angels Research Trust (DART)

Dana's Angels Research Trust (DART)

Dana's Angels Research Trust for Niemann-Pick

Dana's Angels Research Trust (DART)

Dana's Angels Research Trust (DART)

Dana's Angels Research Trust for Niemann-Pick

  • Niemann-Pick Type C
    • Research
    • General Grant Guidelines
    • Resources
    • Links
  • Get Involved
  • About DART
    • Our Leadership
    • A Tribute to Dana
    • DART Documents
    • Contact DART
  • Past Events
  • News Blog
  • Upcoming Events
  • Press Info
  • Donate Now
Announcements Banner News Niemann-Pick Type C News Research News

Mandos Submits New Drug Application to U.S. FDA for Adrabetadex in Infantile-Onset NPC!

Announcements Banner News Niemann-Pick Type C News Research News

Adrabetadex (Cyclodextrin) receives FDA Breakthrough Therapy Designation for Individuals with Infantile-Onset NPC

Announcements Banner News DART News DART Walk/Run

2025 Annual DART to the Finish Charity Walk Raises Over $160,000

Banner News Niemann-Pick Type C News Research News

Great Data On Adrabetadex/Cyclodextrin Released By Mandos Health

Banner News Research News

Azafaros Secures €132M in Financing to advance Phase 3 clinical programs, including NPC

Banner News Niemann-Pick Type C News Research News

Zevra Therapeutics to Sell Priority-Review Voucher for $150 Million related to NPC drug approval

Announcements Banner News Niemann-Pick Type C News Research News

FDA Approves 2nd New Drug to Treat NPC

Announcements Banner News Niemann-Pick Type C News Research News

FDA Approves 1st Treatment for NPC

Banner News Niemann-Pick Type C News Research News

FDA Rare Disease Innovation Hub to Enhance and Advance Outcomes for Patients

Research News

New biotech Mandos to take over Adrabetadex (Cyclodextrin) drug trial

Adrabetadex (Cyclodextrin) Clinical Trial.  As many of you may know, much to the surprise of the NPC community, Mallinckrodt in January 2021 abandoned the Adrabetadex clinical trials; which Andrew Marella has been a part of for over 7 years.  Much of the NPC community’s efforts since that announcement had been focused on what would come …

Read more
May 14, 2021September 17, 2025
Announcements DART News

Town of Greenwich Proclaims February 26, 2021 as ‘Rare Disease Awareness Day’

DART participated in the town of Greenwich’s second annual, and this year, “virtual” rare disease awareness day. “It was truly and honor for the second year to join other families in Greenwich who are fighting to make a real difference in the lives of those suffering from some of the more than 7,000 rare diseases.” …

Read more
February 27, 2021August 9, 2022
DART Walk/Run Upcoming DART Events

DART To The Finish Charity Walk for NPC 2021 – Saturday * Sept. 25, 2021 * 8:30a

Gather your friends and family and join us for an invigorating  2.0 mile walk around beautiful Tod’s Point in Old Greenwich, help us raise much needed funds to find a cure for Niemann-Pick type C disease. No beach pass, no problem, DART has you covered. All Greenwich and CT COVID-19 guidelines will be followed for …

Read more
February 10, 2021September 1, 2021

Posts navigation

Older posts
Newer posts
Donate Now

Donate Now

Shop Now

Read Past Posts

Dana's Angels Research Trust
15 E. Putnam Avenue, #117
Greenwich, CT 06830-5424
Telephone: 1-203-861-2063
FAX 1-203-861-1522
email us info@danasangels.org
Copyright Dana's Angels Research Trust 2002-2022, All rights reserved Blossom PinThis | Developed By Blossom Themes. Powered by WordPress.